These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9181259)

  • 1. Do we achieve maximum medical therapy for patients with chronic ischemic heart disease?
    Conti CR
    Clin Cardiol; 1997 Jun; 20(6):509. PubMed ID: 9181259
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The evaluation of the antianginal effect of Corvaton-Retard in patients with ischemic heart disease by using paired bicycle ergometry].
    Runovich AA; Verkhozin IA; Kuril'skaia TE; Zuev AV
    Ter Arkh; 1997; 69(9):51-2. PubMed ID: 9411828
    [No Abstract]   [Full Text] [Related]  

  • 4. [Update on the treatment with nitrates in ischemic cardiopathy].
    Lanza GA; Maseri A
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):187-90. PubMed ID: 12497905
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative evaluation of the effect of anaprilin and teonikol on thrombocyte aggregation indices in patients with ischemic heart disease from older age groups].
    Pristrom MS; Mrochek AG; Gorbachev VV; Tiabut TD
    Ter Arkh; 1992; 64(10):79-82. PubMed ID: 1485264
    [No Abstract]   [Full Text] [Related]  

  • 6. [Administration of prostaglandin E1 in the treatment of patients with chronic lower limbs critical ischemia with concomitant ischemic heat disease].
    Krotovskiĭ GS; Zudin AM; Kotov AE; Uchkin IG; Zasorina MA; Mosesov AG
    Khirurgiia (Mosk); 2004; (3):31-4. PubMed ID: 15097985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial cytoprotection with trimetazidine in patients with ischemic heart disease during surgical stress].
    Afanas'eva IV; Goncharova LL; Miroshnichenko AG; Petrash VV; Pokrovskaia LA
    Vestn Khir Im I I Grek; 1999; 158(5):34-7. PubMed ID: 10645577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
    Kalinina EB; Komissarova IA; Zaslavskaia RM; Zhdanov IuA
    Klin Med (Mosk); 2002; 80(5):50-3. PubMed ID: 12087889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological preconditioning as a way of the increasing of myocytes resistance to ischemia].
    Wilczewski P; Poloński L
    Wiad Lek; 2000; 53(7-8):449-53. PubMed ID: 11070768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS; Sandell EP
    Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arginine - a new effective drug in ischaemic heart disease?].
    Bednarz B
    Kardiol Pol; 2003 Sep; 59(9):248-52. PubMed ID: 14618203
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of trimetazidine in management of ischemic cardiomyopathy.
    Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC
    Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic treatment of myocardial ischaemia.
    Ferrari R
    Eur Heart J; 1999 Aug; 20(16):1144-5. PubMed ID: 10448019
    [No Abstract]   [Full Text] [Related]  

  • 14. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
    Labrid C
    Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
    Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
    Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
    Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between circadian rhythm and ischemic heart disease, and its implication for nitrate patch utilization.
    Chen Y; Cua JV
    Nurse Pract; 1997 Mar; 22(3):236-8. PubMed ID: 9078524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative efficacy of conservative and surgical treatment of ischemic heart disease in long-term prospective follow-up studies].
    Chernov SA
    Klin Med (Mosk); 2001; 79(11):29-32. PubMed ID: 11811104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of cardiovascular therapy on risk of the development of ischemia and myocardial infarction in the postoperative period in cancer patients with ischemic heart diseases].
    Stetsenko AE; Kassil' VL; Ushakova TI
    Anesteziol Reanimatol; 2001; (5):55-7. PubMed ID: 11757304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.